Bluemoor Health reports quarterly revenue above the internal plan
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
Bluemoor Health
Healthcare · Medical Devices
Updated UTC
146,21 US$
+1,91+1,32 %
After hours145,56 US$−0,44 %
| Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 12,63 md | 14,13 md | 15,19 md | 15,96 md | 17,26 md |
| Gross profit | 7,23 md | 8,43 md | 8,68 md | 9,28 md | 10,31 md |
| Operating income | 2,62 md | 3,12 md | 3,2 md | 2,99 md | 3,14 md |
| Net income | 1,87 md | 1,82 md | 2,38 md | 2,03 md | 2,49 md |
Develops remote-monitoring hardware and clinical software for chronic-care providers.
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
The company approved a multi-year capital program intended to shorten lead times for its largest customers.
Market Wire
A sell-side desk kept a neutral rating while noting that near-term estimates already reflect steady execution.
Sector Desk
The board named an internal candidate with prior treasury and investor-relations experience to the role.
Market Wire
The authorization covers a modest slice of the float and will be funded from operating cash flow.
Market Wire